MEDIZONE INTERNATIONAL INC
8-K, 1996-08-05
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: MERCHANTS & MANUFACTURERS BANCORPORATION INC, 10-Q, 1996-08-05
Next: MCNEIL REAL ESTATE FUND XXIV LP, SC 13D/A, 1996-08-05




                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                           CURRENT REPORT ON FORM 8-K

                         Pursuant to Section 13 or 15(d)
                     of the Securities Exchange Act of 1934




                          Date of Report: July 31, 1996
                        (Date of Earliest event reported)


                       ---------------------------------

                          MEDIZONE INTERNATIONAL, INC.

                       ---------------------------------

             (Exact name of Registrant as specified in its charter)




  Nevada                      2-93277-D                           87-0412648
  ------                      ---------                           ----------
  State of                    Commission                          IRS Taxpayer
  Incorporation               Registration No.                    I.D. Number




            123 East 54th Street, Suite 7B, New York, New York 10022
            --------------------------------------------------------
                     Address of Principal executive offices


                  Registrant's telephone number: (212) 421-0303
                                                 --------------

<PAGE>

Item 5.  Other Events
         ------------

     On July 31, 1996,  the Board of Directors of Medizone  International,  Inc.
(the "Company"), pursuant to the Company's By-Laws, appointed Howard L. Feinsand
and Lawrence I. Sosnow to the Company's Board of Directors.  Messrs.  Feinsand's
and Sosnow's biographies are set forth below.

     Howard L. Feinsand, age 48, is Executive Managing Director and Principal of
Choir  Capital  Ltd.  ("Choir"),  a New York  investment  banking  firm which he
co-founded in 1996. Choir is primarily engaged in the securitization business as
principal,  asset manager and advisor.  Mr.  Feinsand is also a director of Duke
Realty Investments, Inc., a New York Stock Exchange-listed fully integrated real
estate investment trust. From 1995 to 1996, Mr. Feinsand was a Managing Director
of Citicorp North America, Inc., in New York, with responsibility for its Global
Aviation  Products  activities.  From 1989 to 1995,  Mr.  Feinsand  was a senior
manager  (culminating  with his position as Senior Vice  President and Manager -
Capital Markets,  Pricing and Investor Programs) of GE Capital Aviation Services
Limited and its corporate  predecessor,  Polaris Aircraft  Leasing  Corporation.
From 1971 to 1989,  Mr.  Feinsand  practiced  law as a partner in three New York
City law firms, advising  institutional and entrepreneurial  clients regarding a
broad range of corporate  finance,  direct  investment  and other  matters.  Mr.
Feinsand  received a Bachelors of Arts degree from Temple University in 1968 and
a Juris Doctor degree from St. John's University School of Law in 1971.

     Lawrence I.  Sosnow,  age 61, is the Vice  Chairman of Patient  Care,  Inc.
("Patient Care"), a West Orange,  New Jersey home health care company,  which he
co-founded in 1975. Mr. Sosnow was the Chief  Executive  Officer of Patient Care
from 1975 until 1995.  Patient Care is a  subsidiary  of Chemed  Corporation,  a
Cincinnati,  Ohio based New York Stock  Exchange-listed  company. Mr. Sosnow was
the Chairman  (from 1969 to 1973) and  Co-Chairman  (from 1973 to 1975) of MIND,
Inc., a New York based company  providing  training  systems to large industrial
businesses.  He was in the  advertising  business from 1961 to 1969.  Mr. Sosnow
received a Bachelors in Business  Administration  degree from Upsala  College in
1957.



                  (Remainder of page intentionally left blank)

                                        2


<PAGE>

                                   SIGNATURES
                                   ----------

     Pursuant to the  requirements of the Securities Act of 1934, the Registrant
has  duly  caused  this  Current  Report  to be  signed  on  its  behalf  by the
undersigned, one of its officers thereunto duly authorized.

Dated:  New York, NY
        August 1, 1996

                                                   MEDIZONE INTERNATIONAL, INC.



                                                   By: /s/Joseph S. Latino    
                                                       ------------------------
                                                       Joseph S. Latino
                                                       President


                                        3


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission